Billionaire Richard Chilton’s 10 Stock Picks with Huge Upside Potential

3. Thermo Fisher Scientific Inc. (NYSE:TMO)

Chilton Investment Company’s stake: $25,002,774

Upside Potential: 31.95%

Number of Hedge Fund Holders: 100

Thermo Fisher Scientific Inc. (NSE:TMO) is a global leader in serving science, offering innovative technologies and services to customers in pharmaceuticals, biotech, healthcare, research, and industrial sectors. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products & Biopharma Services. The Life Sciences Solutions segment supports drug research and production, while Analytical Instruments provides tools for scientific analysis. The Specialty Diagnostics segment focuses on diagnostic products for healthcare and industrial labs, and the Laboratory Products & Biopharma Services segment offers lab essentials and pharmaceutical services. Thermo Fisher’s goal is to enhance productivity and innovation through a comprehensive portfolio of products and services.

Thermo Fisher Scientific Inc. (NYSE:TMO) reported strong Q1 2025 results, with revenue of $10.36 billion and adjusted EPS of $5.15, exceeding expectations. Despite challenges in the macro environment, the company delivered solid growth, with key areas such as bioproduction and pharma services leading the way. Innovation played a significant role, with new product launches including the Thermo Scientific Vulcan automated lab and the Transcend chromatography platform. The company also continued to strengthen its commercial engine, exemplified by its growing leadership in clinical research. Thermo Fisher announced the acquisition of SOVENTUM’s purification and filtration business for $4.1 billion, expanding its bioproduction capabilities. In terms of capital return, $1 billion in shares were repurchased, and the dividend was increased by 10%. For the full year, Thermo Fisher updated its guidance, projecting revenue between $43.3 billion and $44.2 billion and adjusted EPS between $21.76 and $22.84.